138 related articles for article (PubMed ID: 9298303)
1. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
Joaquim AI; Sagarra AJ; Ramos CD; Coudry R; Sagarra RA; Camargo EE
Clin Nucl Med; 1997 Sep; 22(9):638-40. PubMed ID: 9298303
[No Abstract] [Full Text] [Related]
2. Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
Ardavanis A; Orphanos G; Skafida S; Basioukas S; Rigatos G
Ann Oncol; 2008 Jul; 19(7):1360-1361. PubMed ID: 18534961
[No Abstract] [Full Text] [Related]
3. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
Liu ZZ; Lu ZD; Zhang HW; Yang H; Liu H; Li LF; Li WL; Cui SD
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
Ost E; Illiger HJ
Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
[No Abstract] [Full Text] [Related]
7. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
8. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
9. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma.
Beresford M; Lyburn I; Sanghera B; Makris A; Wong WL
Breast J; 2007; 13(4):424-5. PubMed ID: 17593051
[No Abstract] [Full Text] [Related]
10. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
12. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
Maini CL; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti ML; Vici P; Lopez M; Botti C
J Nucl Med; 1997 Oct; 38(10):1546-51. PubMed ID: 9379190
[TBL] [Abstract][Full Text] [Related]
14. Patients' concerns about clinical trials in Japan.
Aoki E
Lancet; 1999 Mar; 353(9157):1019-20. PubMed ID: 10459946
[No Abstract] [Full Text] [Related]
15. Bone metabolic markers in the evaluation of bone scan flare phenomenon in bone metastases of breast cancer.
Koizumi M; Matsumoto S; Takahashi S; Yamashita T; Ogata E
Clin Nucl Med; 1999 Jan; 24(1):15-20. PubMed ID: 9890487
[TBL] [Abstract][Full Text] [Related]
16. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
[No Abstract] [Full Text] [Related]
17. Paradoxical effect of cytotoxic chemotherapy on anemia in cancer patients with beta-thalassemia minor.
Del Mastro L; Venturini M; Costantini M; Garrone O; Sertoli MR; Bertelli G; Machì AM; Rosso R
J Natl Cancer Inst; 1997 Mar; 89(6):455-6. PubMed ID: 9091649
[No Abstract] [Full Text] [Related]
18. Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report.
Grosso M; Imran MB; Volterrani D; Roncella M; Abufalgha K; Grassetto G; Al-Nahhas A; Rubello D; Mariani G
Nucl Med Rev Cent East Eur; 2008; 11(2):70-2. PubMed ID: 19585458
[TBL] [Abstract][Full Text] [Related]
19. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
